Eye Center Medical & Surgica1L Cheshire, CT - 06410

Eye Center Medical & Surgica1L is categorized under Health Services in Cheshire, CT and active since 2006.

Eye Center Medical & Surgica1L was established in 2006, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Health Services business, which does work in the B2C market, and is classified as a Health Services, under code number 6214981 by the NAICS.

If you are seeking more information, feel free to contact Paul E Masi at the company’s single location by writing to 415 Highland Avenue # 1, Cheshire, Connecticut CT 06410 or by phoning (203) 272-5494. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Eye Center Medical & Surgica1L
Contact Person: Paul E Masi
Address: 415 Highland Avenue # 1, Cheshire, Connecticut 06410
Phone Number: (203) 272-5494
Website Address: eyecenterct.com
Annual Revenue (USD): $500.000 to $999.999
Founded: 2006
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Health Services
SIC Code: 8099
NAICS Code: 6214981
Share This Business:

Eye Center Medical & Surgica1L was started in 2006 to provide professional Health Services under the SIC code 8099 and NAICS code 6214981. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.

Feel free to contact Paul E Masi for inquiries that concern Eye Center Medical & Surgica1L by calling the company number (203) 272-5494, as your correspondence is most welcome. Additionally, the physical location of the single location of Eye Center Medical & Surgica1L can be found at the coordinates 41.5089,-72.89973 as well as the street address 415 Highland Avenue # 1 in Cheshire, Connecticut 06410.

For its online presence, you may visit Eye Center Medical & Surgica1L’s website at eyecenterct.com and engage with its social media outlets through on Twitter and on Facebook.